ACV AUCTIONS INC-A (ACVA) Stock Fundamental Analysis
NYSE:ACVA - New York Stock Exchange, Inc. - US00091G1040 - Common Stock - Currency: USD
Taking everything into account, ACVA scores 3 out of 10 in our fundamental rating. ACVA was compared to 84 industry peers in the Commercial Services & Supplies industry. ACVA scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ACVA is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year ACVA has reported negative net income.
In the past year ACVA had a positive cash flow from operations.
In the past 5 years ACVA always reported negative net income.
In multiple years ACVA reported negative operating cash flow during the last 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of -6.43%, ACVA is doing worse than 69.05% of the companies in the same industry.
The Return On Equity of ACVA (-16.85%) is worse than 65.48% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -6.43% | ||
| ROE | -16.85% | ||
| ROIC | N/A |
ROA(3y)-9.14%
ROA(5y)-9.1%
ROE(3y)-18.55%
ROE(5y)-17.56%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
ACVA's Gross Margin of 52.64% is amongst the best of the industry. ACVA outperforms 90.48% of its industry peers.
In the last couple of years the Gross Margin of ACVA has grown nicely.
The Profit Margin and Operating Margin are not available for ACVA so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 52.64% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.78%
GM growth 5Y18.27%
2. Health
2.1 Basic Checks
ACVA does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ACVA has more shares outstanding
ACVA has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, ACVA has a worse debt to assets ratio.
2.2 Solvency
ACVA has an Altman-Z score of 1.70. This is a bad value and indicates that ACVA is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.70, ACVA is in line with its industry, outperforming 41.67% of the companies in the same industry.
The Debt to FCF ratio of ACVA is 3.12, which is a good value as it means it would take ACVA, 3.12 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of ACVA (3.12) is better than 73.81% of its industry peers.
A Debt/Equity ratio of 0.38 indicates that ACVA is not too dependend on debt financing.
ACVA has a better Debt to Equity ratio (0.38) than 61.90% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.38 | ||
| Debt/FCF | 3.12 | ||
| Altman-Z | 1.7 |
ROIC/WACCN/A
WACC8.58%
2.3 Liquidity
ACVA has a Current Ratio of 1.50. This is a normal value and indicates that ACVA is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.50, ACVA is in line with its industry, outperforming 46.43% of the companies in the same industry.
ACVA has a Quick Ratio of 1.50. This is a normal value and indicates that ACVA is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.50, ACVA is in line with its industry, outperforming 58.33% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.5 | ||
| Quick Ratio | 1.5 |
3. Growth
3.1 Past
ACVA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 17.02%, which is quite good.
The Revenue has grown by 32.40% in the past year. This is a very strong growth!
ACVA shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 42.93% yearly.
EPS 1Y (TTM)17.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%60%
Revenue 1Y (TTM)32.4%
Revenue growth 3Y21.14%
Revenue growth 5Y42.93%
Sales Q2Q%20.59%
3.2 Future
The Earnings Per Share is expected to grow by 45.81% on average over the next years. This is a very strong growth
Based on estimates for the next years, ACVA will show a quite strong growth in Revenue. The Revenue will grow by 19.75% on average per year.
EPS Next Y39.86%
EPS Next 2Y42.03%
EPS Next 3Y43%
EPS Next 5Y45.81%
Revenue Next Year22.16%
Revenue Next 2Y22.05%
Revenue Next 3Y23.11%
Revenue Next 5Y19.75%
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
ACVA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 1403.47 indicates a quite expensive valuation of ACVA.
The rest of the industry has a similar Price/Forward Earnings ratio as ACVA.
The average S&P500 Price/Forward Earnings ratio is at 35.34. ACVA is valued rather expensively when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 1403.47 |
4.2 Price Multiples
The rest of the industry has a similar Price/Free Cash Flow ratio as ACVA.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 37.57 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as ACVA's earnings are expected to grow with 43.00% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y42.03%
EPS Next 3Y43%
5. Dividend
5.1 Amount
ACVA does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
11.71
+0.42 (+3.72%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners104.27%
Inst Owner Change3.05%
Ins Owners2.46%
Ins Owner Change26.97%
Market Cap2.00B
Analysts84
Price Target23.59 (101.45%)
Short Float %8.26%
Short Ratio8.64
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)7.36%
Min EPS beat(2)-9.21%
Max EPS beat(2)23.94%
EPS beat(4)3
Avg EPS beat(4)9.38%
Min EPS beat(4)-9.21%
Max EPS beat(4)23.94%
EPS beat(8)6
Avg EPS beat(8)8.94%
EPS beat(12)10
Avg EPS beat(12)16.96%
EPS beat(16)13
Avg EPS beat(16)18.25%
Revenue beat(2)0
Avg Revenue beat(2)-0.93%
Min Revenue beat(2)-1.63%
Max Revenue beat(2)-0.24%
Revenue beat(4)2
Avg Revenue beat(4)0.91%
Min Revenue beat(4)-1.63%
Max Revenue beat(4)4.71%
Revenue beat(8)3
Avg Revenue beat(8)0.15%
Revenue beat(12)5
Avg Revenue beat(12)0.48%
Revenue beat(16)8
Avg Revenue beat(16)3.02%
PT rev (1m)0.36%
PT rev (3m)2.78%
EPS NQ rev (1m)1.47%
EPS NQ rev (3m)11.72%
EPS NY rev (1m)0%
EPS NY rev (3m)7.63%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.34%
Revenue NY rev (1m)-0.1%
Revenue NY rev (3m)0.15%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 1403.47 | ||
| P/S | 2.97 | ||
| P/FCF | 37.57 | ||
| P/OCF | 22.5 | ||
| P/B | 4.56 | ||
| P/tB | 20.49 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.39
EYN/A
EPS(NY)0.01
Fwd EY0.07%
FCF(TTM)0.31
FCFY2.66%
OCF(TTM)0.52
OCFY4.45%
SpS3.94
BVpS2.57
TBVpS0.57
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -6.43% | ||
| ROE | -16.85% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 52.64% | ||
| FCFM | 7.91% |
ROA(3y)-9.14%
ROA(5y)-9.1%
ROE(3y)-18.55%
ROE(5y)-17.56%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.78%
GM growth 5Y18.27%
F-Score5
Asset Turnover0.59
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.38 | ||
| Debt/FCF | 3.12 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 90.33% | ||
| Cap/Sales | 5.3% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.5 | ||
| Quick Ratio | 1.5 | ||
| Altman-Z | 1.7 |
F-Score5
WACC8.58%
ROIC/WACCN/A
Cap/Depr(3y)148.24%
Cap/Depr(5y)145.57%
Cap/Sales(3y)5.59%
Cap/Sales(5y)4.99%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)17.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%60%
EPS Next Y39.86%
EPS Next 2Y42.03%
EPS Next 3Y43%
EPS Next 5Y45.81%
Revenue 1Y (TTM)32.4%
Revenue growth 3Y21.14%
Revenue growth 5Y42.93%
Sales Q2Q%20.59%
Revenue Next Year22.16%
Revenue Next 2Y22.05%
Revenue Next 3Y23.11%
Revenue Next 5Y19.75%
EBIT growth 1Y17.17%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year185.53%
EBIT Next 3Y70.4%
EBIT Next 5Y45.06%
FCF growth 1Y316.2%
FCF growth 3Y-24.1%
FCF growth 5YN/A
OCF growth 1Y12133.2%
OCF growth 3Y-8.47%
OCF growth 5YN/A